NCT06023654

Brief Summary

Circadian rest-Activity Rhythm disorders (CARDs) are common in patients with cancer, particularly in advanced disease. CARDs are associated with increased symptoms, poorer quality of life, poorer response to anticancer treatments and shorter survival. The goal of this observational study is to see how common CARDs are in patients with advanced cancer and to characterise their rest and activity patterns in more detail. A recent study has outlined a standard way to assess and diagnose a CARD. This study aims to assess patients with advanced cancer for a CARD using a novel screening tool against this newly formed diagnostic criteria. Potentially modifiable risk factors will be considered along with associations between CARDs and symptoms, sleep preferences, sleep quality, daytime sleepiness, quality of life measures and predictors of survival.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2023

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 9, 2022

Completed
8 months until next milestone

Study Start

First participant enrolled

May 15, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

September 5, 2023

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2024

Completed
7 days until next milestone

Study Completion

Last participant's last visit for all outcomes

May 22, 2024

Completed
Last Updated

April 3, 2025

Status Verified

March 1, 2025

Enrollment Period

1 year

First QC Date

September 9, 2022

Last Update Submit

March 31, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • To measure preliminary concurrent validity of a novel screening tool to identify Circadian rest-Activity Rhythm Disorders in patients with advanced cancer against diagnostic criteria

    Assessing the sensitivity and specificity of the screening tool

    Time 1 (baseline), Time 2 (after 72 consecutive hours of accelerometry monitoring)

Secondary Outcomes (18)

  • To measure test-retest reliability of a novel screening tool to identify Circadian rest-Activity Rhythm Disorders in patients with advanced cancer

    Time 1 (baseline), Time 2 (after 72 consecutive hours of accelerometry monitoring)

  • To measure acceptability and ease of use of a novel screening tool to identify Circadian rest-Activity Rhythm Disorders in patients with advanced cancer

    Time 2 (after 72 consecutive hours of accelerometry monitoring)

  • To measure acceptability and ease of use of a novel sleep and activity diary in patients with advanced cancer

    Time 2 (after 72 consecutive hours of accelerometry monitoring)

  • To identify the incidence of Circadian rest-activity Rhythm Disorders in patients with advanced cancer

    Time 2 (after 72 consecutive hours of accelerometry monitoring)

  • To assess rest and physical activity patterns in patients with advanced cancer

    Time 2 (after 72 consecutive hours of accelerometry monitoring)

  • +13 more secondary outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with locally advanced or metastatic cancer

You may qualify if:

  • Adult (18 years of age or older)
  • Locally advanced or metastatic cancer
  • Outpatient
  • Ambulatory
  • Prognosis of 3 months or more

You may not qualify if:

  • Inpatient
  • Shiftworker
  • Recent long-haul travel
  • Cognitive impairment impacting on ability to complete questionnaires

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Our Lady's Hospice & Care Services

Dublin, Ireland

Location

St James's Hospital

Dublin, Ireland

Location

MeSH Terms

Conditions

NeoplasmsChronobiology DisordersParasomniasMotor Activity

Condition Hierarchy (Ancestors)

Nervous System DiseasesSleep Wake DisordersMental DisordersBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Palliative Medicine

Study Record Dates

First Submitted

September 9, 2022

First Posted

September 5, 2023

Study Start

May 15, 2023

Primary Completion

May 15, 2024

Study Completion

May 22, 2024

Last Updated

April 3, 2025

Record last verified: 2025-03

Locations